Evidence map›Paper›PMID 27197878›Full record

ArticleScientific reports2016

Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.

Eva Garcia-Alegria, Maria Iliut, Monika Stefanska, Claudio Silva, Sebastian Heeg, Susan J Kimber, Valerie Kouskoff, Georges Lacaud, Aravind Vijayaraghavan, Kiran Batta

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Eva Garcia-AlegriaCancer Research UK Stem Cell Hematopoiesis Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.
Maria IliutSchool of Materials and National Graphene Institute, University of Manchester, UK.
Monika StefanskaCancer Research UK Stem Cell Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.
Claudio SilvaSchool of Materials and National Graphene Institute, University of Manchester, UK.
Sebastian HeegSchool of Materials and National Graphene Institute, University of Manchester, UK.
Susan J KimberFaculty of Life Sciences, Michael Smith Building, Manchester, United Kingdom.
Valerie KouskoffCancer Research UK Stem Cell Hematopoiesis Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.
Georges LacaudCancer Research UK Stem Cell Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.
Aravind VijayaraghavanSchool of Materials and National Graphene Institute, University of Manchester, UK.
Kiran BattaCancer Research UK Stem Cell Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.
University of Manchester · GBCancer Research UK Manchester Institute · GBHenry Royce Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I001794/1Cancer Research UK 12486Cancer Research UK 19565Medical Research Council G080/057/87486Medical Research Council G0801057
6 · The paper itself

Abstract

Pluripotent stem cells represent a promising source of differentiated tissue-specific stem and multipotent progenitor cells for regenerative medicine and drug testing. The realisation of this potential relies on the establishment of robust and reproducible protocols of differentiation. Several reports have highlighted the importance of biomaterials in assisting directed differentiation. Graphene oxide (GO) is a novel material that has attracted increasing interest in the field of biomedicine. In this study, we demonstrate that GO coated substrates significantly enhance the differentiation of mouse embryonic stem (ES) cells to both primitive and definitive haematopoietic cells. GO does not affect cell proliferation or survival of differentiated cells but rather enhances the transition of haemangioblasts to haemogenic endothelial cells, a key step during haematopoietic specification. Importantly, GO also improves, in addition to murine, human ES cell differentiation to blood cells. Taken together, our study reveals a positive role for GO in haematopoietic differentiation and suggests that further functionalization of GO could represent a valid strategy for the generation of large numbers of functional blood cells. Producing these cells would accelerate haematopoietic drug toxicity testing and treatment of patients with blood disorders or malignancies.

Indexed as

AnimalsBlood CellsCell DifferentiationCell ProliferationCell SurvivalCoated Materials, BiocompatibleEmbryonic Stem CellsGraphiteHematopoietic Stem CellsHuman Embryonic Stem CellsHumansMiceMouse Embryonic Stem CellsMyeloid CellsCoated Materials, BiocompatibleGraphite

Identifiers

PMID27197878
PMCPMC4873758
OpenAlexW2394932051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.